Delivery Order SPE2DB20D3505-SPE2DB23FT5W5
- Not listed
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,554.45. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of SHINGRIX vaccine kits to the Defense Logistics Agency (DLA), a defense agency. The $4,750.75 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This single-award...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm fixed-price contract has a ceiling value of $34,267.50 and a completion date of December 4, 2024. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $6,813.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 19, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The $1,987.36 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award represents a delivery order under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $10,803.53 and is a delivery order with a firm fixed-price pricing type. The contract has an ultimate completion date of May 15, 2023, and was awarded on May 12, 2023. This...
- This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.42, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 8, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $19,003.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,531.94, is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant...
- This federal contract award is for the delivery of SHINGRIX vial kits, a vaccine product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $10,690.10 with a completion date of January 26, 2023. This is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT5W5Delivery Order
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $14,088.78, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of January 23, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 1/20/23 |